Man Group
ABEO icon

Man Group’s Abeona Therapeutics ABEO Stock Holding History

Man Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,794
Closed -$67K – 2184
2025
Q2 		$67K Buy
+11,794
New +$67.1K ﹤0.01% 2135
2024
Q2 		– Sell
-73,824
Closed -$535K – 2003
2024
Q1 		$535K Buy
+73,824
New +$468K ﹤0.01% 1756
2018
Q4 		– Sell
-837
Closed -$267K – 1886
2018
Q3 		$267K Buy
+837
New +$297K ﹤0.01% 1976

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Man Group's ABEO Position: Q3 2025 in Review

Man Group sold out of Abeona Therapeutics (ABEO) in Q3 2025, closing a stake of 11,794 shares — an estimated $67K sold.

Man Group first reported a position in ABEO in Q3 2018 and held it in 3 quarters. The position peaked at $535K in Q1 2024. 100 funds tracked by Wall St. Rank hold ABEO as of Q3 2025.

  • Man Group reported no remaining Abeona Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 11,794 Abeona Therapeutics shares in Q3 2025, an estimated $67K.
  • Man Group first reported a position in Abeona Therapeutics in Q3 2018 and held it in 3 quarters.
  • Man Group's Abeona Therapeutics position peaked at $535K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.